Charter Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$739K Sell
616
-14
-2% -$14.3K 0.33% 26
2026
Q1
$580K Buy
630
+1
+0.2% +$1.01K 0.29% 30
2025
Q4
$676K Hold
629
0.35% 26
2025
Q3
$480K Hold
629
0.26% 40
2025
Q2
$491K Buy
+629
New +$489K 0.29% 37

Other funds holding LLY

Charter Capital Management's LLY Position: Q2 2026 in Review

Charter Capital Management reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $14.3K and leaving 616 shares worth $739K. The position accounts for 0.33% of the portfolio, ranked #26.

Charter Capital Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Charter Capital Management held 616 shares of Eli Lilly worth $739K as of Q2 2026.
  • Charter Capital Management sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
  • Eli Lilly made up 0.33% of Charter Capital Management's portfolio in Q2 2026, its #26 holding.
  • Charter Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Charter Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.